Biochemistry · Iron Metabolism
Iron is an essential micronutrient critical for numerous biological processes, including oxygen transport, DNA synthesis, and cellular respiration. Its metabolism is tightly regulated due to its potential toxicity in excess and its indispensable role in redox reactions. The body maintains iron homeostasis through a complex interplay of absorption, transport, storage, and recycling mechanisms, primarily mediated by specialized proteins and regulatory pathways.
Disruptions in iron metabolism can lead to severe clinical consequences, such as iron-deficiency anemia or iron overload disorders like hemochromatosis. Understanding the biochemical pathways of iron absorption, storage, and regulation is fundamental for diagnosing and managing these conditions. The liver, duodenum, and reticuloendothelial system play central roles in maintaining systemic iron balance.
Dietary iron exists in two forms: heme iron (derived from hemoglobin and myoglobin in animal products) and non-heme iron (found in plant-based foods). Heme iron is absorbed more efficiently via the heme carrier protein 1 (HCP1) in duodenal enterocytes. Non-heme iron, primarily in the ferric (Fe³⁺) state, is reduced to ferrous (Fe²⁺) iron by duodenal cytochrome b (Dcytb) before being transported into enterocytes via divalent metal transporter 1 (DMT1). Absorption is regulated by body iron stores and erythropoietic demand.
Once absorbed, iron is exported from enterocytes into the bloodstream via ferroportin, the only known iron exporter. In the plasma, iron is oxidized to Fe³⁺ by hephaestin or ceruloplasmin and binds to transferrin, a glycoprotein that transports iron to tissues. Each transferrin molecule can bind two Fe³⁺ ions, and transferrin saturation is a key clinical marker of iron status. The transferrin-iron complex is internalized by cells via transferrin receptor 1 (TfR1)-mediated endocytosis.
Excess iron is stored primarily in the liver, spleen, and bone marrow within ferritin, a multimeric protein complex that can sequester up to 4,500 iron atoms. Ferritin consists of 24 subunits of heavy (H) and light (L) chains, with the H-chain exhibiting ferroxidase activity to oxidize Fe²⁺ to Fe³⁺ for storage. Hemosiderin, a partially degraded form of ferritin, accumulates in conditions of iron overload and is visible histologically with Prussian blue staining. Serum ferritin levels are a critical indicator of body iron stores.
Systemic iron homeostasis is primarily regulated by hepcidin, a peptide hormone produced by the liver. Hepcidin binds to ferroportin, inducing its internalization and degradation, thereby inhibiting iron export from enterocytes, macrophages, and hepatocytes. Hepcidin expression is upregulated by iron overload and inflammation (via IL-6) and downregulated by iron deficiency, hypoxia, and increased erythropoiesis. The bone morphogenetic protein (BMP)/SMAD signaling pathway and the HFE/TfR2 complex are key regulators of hepcidin transcription.
Approximately 90% of the body's daily iron requirement is met through recycling of senescent red blood cells by macrophages in the spleen, liver, and bone marrow. Hemoglobin is degraded, and iron is released from heme by heme oxygenase-1 (HO-1). The liberated iron is either stored in ferritin or exported via ferroportin for reuse in erythropoiesis. This recycling process is highly efficient and minimizes the need for dietary iron absorption under normal conditions.
Iron metabolism is a tightly regulated process involving absorption, transport, storage, and recycling. Key proteins include DMT1 (absorption), transferrin (transport), ferritin (storage), and ferroportin (export). Hepcidin serves as the central regulator of systemic iron homeostasis by modulating ferroportin activity. Disruptions in these pathways can lead to iron-deficiency anemia or iron overload disorders.
Iron-deficiency anemia is characterized by low serum ferritin, low transferrin saturation, and elevated soluble transferrin receptor levels. In contrast, iron overload disorders such as hereditary hemochromatosis result from mutations in HFE, TfR2, or hepcidin, leading to excessive iron absorption and deposition in organs. Measurement of serum ferritin, transferrin saturation, and hepcidin levels are essential for diagnosing and monitoring these conditions.
Chronic inflammation can lead to anemia of chronic disease due to elevated hepcidin levels, which sequester iron in macrophages and reduce its availability for erythropoiesis. Conversely, ineffective erythropoiesis (e.g., in thalassemia) suppresses hepcidin, resulting in iron overload. Understanding these mechanisms is crucial for developing targeted therapies, such as hepcidin agonists or antagonists.